
The Journal of Supercritical Fluids, Journal Year: 2024, Volume and Issue: 215, P. 106422 - 106422
Published: Oct. 3, 2024
Language: Английский
The Journal of Supercritical Fluids, Journal Year: 2024, Volume and Issue: 215, P. 106422 - 106422
Published: Oct. 3, 2024
Language: Английский
International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 125552 - 125552
Published: April 1, 2025
Language: Английский
Citations
0Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(12), P. 1493 - 1493
Published: Nov. 21, 2024
Background: Nabumetone (NAB) is a poorly soluble nonsteroidal anti-inflammatory prodrug (BCS class II drug) whose solubility significantly improved by complexation with cyclodextrins (CDs). Methods: The solid complexes, in 1:1 molar ratio, were prepared mechanochemical activation grinding, using β-cyclodextrin (β-CD) and its derivatives, hydroxypropyl- sulfobutylether-β-cyclodextrin (HP-β-CD SBE-β-CD). was confirmed differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), attenuated total reflectance Fourier-transformed infrared spectroscopy (ATR–FTIR). Obtained products further characterized regarding their solubility, vitro dissolution, permeability chemical stability. Results: Co-grinding HP-β-CD SBE-β-CD yielded that showed dissolution profiles hydrochloric acid medium (pH 1.2) substantially different from of pure NAB, yielding efficiency enhancements 34.86 ± 1.64 58.30 0.28 times, respectively, for the optimized products. Their gastrointestinal also studied low-volume environment at pH 6.8, corresponding to intestinal environment. Both β-CD derivatives increased NAB rate mass transport across biomimetic membrane. effect on stability under stress conditions developed validated UHPLC–DAD–HRMS method. In acidic conditions, complexed prone hydrolytic degradation, one degradation product—pharmacologically inactive metabolite. However, oxidative elevated temperatures, 10 identified co-ground samples. All systems stable during photo- long-term studies. Conclusions: complexes are promising candidates pharmaceutical product development.
Language: Английский
Citations
1The Journal of Supercritical Fluids, Journal Year: 2024, Volume and Issue: 215, P. 106422 - 106422
Published: Oct. 3, 2024
Language: Английский
Citations
0